Elekta stock

EKTA.B · Nasdaq Stockholm · SEK

Compare Elekta
kr 60.60Change from previous close: −2.26%Absolute change: −kr 1.40

Close · November 20, 2026

Price history

+42.39% over the period

1 year: from kr 42.56 (November 20, 2025) to kr 60.60 (November 20, 2026), +42.39%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026kr 60.60
October 30, 2026kr 59.70
September 30, 2026kr 52.80
August 31, 2026kr 54.30
July 31, 2026kr 48.38
June 30, 2026kr 49.42
May 29, 2026kr 53.70
April 30, 2026kr 53.25
March 31, 2026kr 55.20
February 27, 2026kr 58.05
January 30, 2026kr 57.20
December 30, 2025kr 56.75
November 28, 2025kr 58.00
November 20, 2025kr 42.56

At a glance

  • The company

    Medical technology company providing radiation therapy, stereotactic radiosurgery, brachytherapy and neurosurgery solutions for cancer and brain disorder treatment

  • Latest results

    Quarter to July 31, 2026 · EPS kr 0.69 (estimate kr 0.46)

TickerLandia's take on Elekta

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk lowkr 42.38
52-wk highkr 66.70

−9.15% from the 52-week high

Analysts · 15 analysts

Average targetkr 59.05−2.56% vs. price

Buy 5 · Hold 3 · Sell 7 · Hold

TickerLandia Fingerprint: Elekta

Compared with similar companies: very low profitability, very low financial strength, and very high dividend.

Financials and price compared with 31 companies in the medical devices industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Elekta is cheaper than similar companies

Elekta's Forward P/E: 12.5, −46% against the median of a group of 11 similar companies (23.1).

Compared with 11 similar companies

Elekta's metrics compared with similar companies
MetricElektaPosition in the groupBand
Forward P/E12.5Low
Operating margin9.2%Low
ROE-4.3%Low
Debt/equity0.90High
Price/book3.18Middle

Grey band: the middle half of the group; tick: the median; dot: Elekta. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

kr 3.54B

Latest quarter · Q to Jul 2026

Net income

kr 264M

Latest quarter · Q to Jul 2026

Quarterly net margin

7.5%

Latest quarter · Q to Jul 2026

Numbers and valuation

Full valuation
Market cap
kr 23.15B
EPS
-kr 0.95
Volume
1.18M
Daily trading
€7.1M
Dividend yield
3.96%

How Elekta is changing

All results
  • Revenue grew 4.0% a year on average over the last 5 years

  • Operating margin fell from 11.8% to 8.2%

  • Profitable in 4 of 5 fiscal years

Returns

Elekta returns with dividends

kr 1,000 invested in Elekta 5 years ago, on November 22, 2021, would be worth kr 684 today with dividends reinvested: −31.58% in total, −7.32% per year. On price alone it would be kr 567 (−43.31%).

PeriodElektakr 1,000 becomes
1 month+8.60%kr 1,086
6 months+1.17%kr 1,012
Year to date+6.78%kr 1,068
1 year+48.75%kr 1,487
3 years−21.15%kr 788
5 years−31.58%kr 684
10 years−3.01%kr 970

From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment

The chart in detail

Elekta: technical analysis

Elekta is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 57.6% below its all-time closing high (kr 143.00, November 14, 2019).

Trend
Upward
RSI (14 sessions)
55
Between 30 and 70
vs 200-session average
+11.37%

Support and resistance

Price areas where Elekta has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistancekr 62.73+3.51%2 touches, last on May 27, 2026
  2. Last pricekr 60.60
  3. Supportkr 59.30−2.15%2 touches, last on January 21, 2026
  4. Supportkr 57.85−4.54%2 touches, last on April 17, 2026
  5. Supportkr 56.50−6.77%3 touches, last on August 24, 2026

Volatility and risk

Volatility (60 sessions, annualised)
27.5%
Largest fall in the last year
−27.75%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Elekta: seasonality

Average monthly price change over 33 years

+3.5%Jan−0.9%Feb+0.4%Mar+0.1%Apr+4.0%May−0.9%Jun+1.3%Jul−0.2%Aug−1.0%Sep+2.2%Oct+6.0%Nov−1.3%Dec

Over the last 33 years, the strongest month for Elekta has been November: +6.05% on average, positive in 20 years out of 32. The weakest has been December: −1.28% on average, positive in 15 years out of 32.

Show chart data
MonthAverageMedianPositive years
January+3.46%+1.27%18 of 32
February−0.94%−1.33%14 of 32
March+0.39%+0.27%16 of 32
April+0.07%+0.56%18 of 33
May+4.04%+6.03%23 of 33
June−0.87%+0.89%17 of 33
July+1.25%+1.45%20 of 33
August−0.23%−2.99%15 of 33
September−1.00%+0.98%17 of 33
October+2.20%+1.99%21 of 33
November+6.05%+1.61%20 of 32
December−1.28%−1.07%15 of 32

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Elekta and its competitors

Radiation therapy equipment for treating cancer is the starting point of Elekta's activities, including linear machines such as Elekta Unity, Elekta Evo and Elekta Versa HD, alongside stereotactic radiosurgery systems such as the Esprit gamma knife. The company also sells brachytherapy products, among them Oncentra Brachy and Elekta Flexitron, and the Leksell Vantage neurosurgery system. Its clinical solutions are offered in the Americas, Europe, the Middle East, Africa and the Asia Pacific, and it provides veterinary radiation therapy solutions as well as clinical and professional services through Elekta Care.

Headquarters
Stockholm, Sweden
Employees
3,996
Founded
1972
Chief executive
Jakob Just-Bomholt
Elekta and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
ElektaEKTA.B$2.27B9.2%—+1.17%
Medacta GroupMOVE$2.41B15.2%27.7−30.49%
GN Store NordGN$2.46B10.9%90.2+22.10%
ChemoMetecCHEMM$1.75B49.1%59.9+99.42%
AmbuAMBU.B$3.4B13.2%36.7+32.33%
El.En.ELN$1.44B14.7%20.7+10.78%

Same industry or related industries, similar size. Compare Elekta with its competitors · Full profile